摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-(Chloromethyl)-2-methoxyphenol | 529502-39-4

中文名称
——
中文别名
——
英文名称
5-(Chloromethyl)-2-methoxyphenol
英文别名
——
5-(Chloromethyl)-2-methoxyphenol化学式
CAS
529502-39-4
化学式
C8H9ClO2
mdl
——
分子量
172.61
InChiKey
LTUZKIDUBAFOGJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.9
  • 重原子数:
    11
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.25
  • 拓扑面积:
    29.5
  • 氢给体数:
    1
  • 氢受体数:
    2

文献信息

  • METHOD FOR PRODUCING A HIGH-PURITY AROMATIC METHYL ALCOHOL AND HIGH-PURITY AROMATIC METHYL ALCOHOL COMPOSITION HAVING EXCELLENT PRESERVATION STABILITY
    申请人:Doi Takashi
    公开号:US20120323021A1
    公开(公告)日:2012-12-20
    An object of the present invention is to provide a high-purity aromatic methyl alcohol compound having reduced a bis(arylmethyl)ether compound as a side product mixed thereinto and a high-purity aromatic methyl alcohol composition having excellent preservation stability and methods for producing them. The object of the present invention is achieved by a method for producing a high-purity aromatic methyl alcohol compound, which comprises obtaining a high-purity aromatic methyl alcohol compound in high yield from an aromatic methyl alcohol-containing crude product by subjecting the crude product to distillation in the presence of an anti-decomposition agent. Further, the object for the preservation stability is achieved by producing a high-purity aromatic methyl alcohol composition using the obtained high-purity aromatic methyl alcohol compound.
    本发明的目的是提供一种高纯度芳香基甲醇化合物,其中混有减少的双(芳基甲基)醚化合物作为副产物,并且具有良好的保存稳定性的高纯度芳香基甲醇组合物及其生产方法。本发明的目的通过以下方法实现:通过在抗分解剂的存在下对含芳香基甲醇的原始产品进行蒸馏,从而高产率地获得高纯度芳香基甲醇化合物。此外,通过使用获得的高纯度芳香基甲醇化合物生产高纯度芳香基甲醇组合物,实现了保存稳定性的目标。
  • METHOD FOR PRODUCING HIGH PURITY AROMATIC METHYL ALCOHOL, AND HIGH PURITY AROMATIC METHYL ALCOHOL COMPOSITION HAVING EXCELLENT STORAGE STABILITY
    申请人:Ube Industries, Ltd.
    公开号:EP2540695A1
    公开(公告)日:2013-01-02
    An object of the present invention is to provide a high-purity aromatic methyl alcohol compound having reduced a bis(arylmethyl) ether compound as a side product mixed thereinto and a high-purity aromatic methyl alcohol composition having excellent preservation stability and methods for producing them. The object of the present invention is achieved by a method for producing a high-purity aromatic methyl alcohol compound, which comprises obtaining a high-purity aromatic methyl alcohol compound in high yield from an aromatic methyl alcohol-containing crude product by subjecting the crude product to distillation in the presence of an anti-decomposition agent. Further, the object for the preservation stability is achieved by producing a high-purity aromatic methyl alcohol composition using the obtained high-purity aromatic methyl alcohol compound.
    本发明的目的是提供一种高纯度芳香族甲醇化合物,其中混有作为副产物的还原双(芳基甲基)醚化合物,以及一种具有优异保存稳定性的高纯度芳香族甲醇组合物及其生产方法。 本发明的目的是通过一种生产高纯度芳香族甲醇化合物的方法来实现的,该方法包括在有抗分解剂存在的情况下,通过对含芳香族甲醇的粗产品进行蒸馏,以高产率从该粗产品中获得高纯度芳香族甲醇化合物。此外,通过使用所获得的高纯度芳香族甲醇化合物生产高纯度芳香族甲醇组合物,还可实现防腐稳定性的目标。
  • [EN] COMPOUNDS WITH ANTI-HELICOBACTER PYLORI ACTIVITY<br/>[FR] COMPOSES AYANT UNE ACTION CONTRE L'HELICOBACTER PYLORI
    申请人:ASTRAZENECA AB
    公开号:WO2001034578A1
    公开(公告)日:2001-05-17
    The invention relates to compounds of formula (I) which have anti-Helicobacter pylori activity.
  • [EN] PROCESS OF PREPARING PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CFTR MEDIATED DISEASES<br/>[FR] PROCÉDÉ DE PRÉPARATION DE COMPOSITIONS PHARMACEUTIQUES POUR LE TRAITEMENT DE MALADIES À MÉDIATION ASSURÉE PAR LE CFTR
    申请人:VERTEX PHARMA
    公开号:WO2015073231A1
    公开(公告)日:2015-05-21
    Processes of preparing pharmaceutical compositions comprising 3-(6-(1-(2,2- difluorobenzo[d][1,3] dioxol-5 -yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid (Compound 1) in Form I and a solid dispersion comprising substantially amorphous N-(5- hydroxy-2,4-ditert-butyl-phenyl)-4-oxo-lH-quinoline-3-carboxamide (Compound 2), methods of treating, lessening the severity of, or symptomatically treating CFTR mediated diseases, such as cystic fibrosis, methods of administering, and kits thereof are disclosed.
查看更多